CAR-T 疗法在 5 天内缩小了 3 名试验患者的侵袭性脑癌肿瘤。 CAR-T therapy shrank aggressive brain cancer tumors in 3 trial patients within 5 days.

一种新的 CAR-T 疗法在侵袭性脑癌临床试验的早期阶段显示出有希望的结果，在短短五天内缩小了肿瘤。 A new CAR-T therapy treatment has shown promising results in the early stages of clinical trials for aggressive brain cancer, shrinking tumors in just five days. 麻省总医院癌症中心的研究人员分享了对胶质母细胞瘤（一种快速生长的脑肿瘤）患者进行新疗法试验的前三名患者的结果。 Researchers from the Mass General Cancer Centre shared results for the first three patients in a trial of the novel treatment on patients with glioblastoma, a fast-growing type of brain tumor. CAR-T 疗法涉及使用患者自身的细胞来对抗癌症，使其成为最个性化的方法。 CAR-T therapy involves using a patient's own cells to fight cancer, making it the most personalized approach.